Further investigation is required to elucidate the molecular events responsible for E-cadherin downregulation associated with overexpression of Nck2 in human primary melanoma cells and whether downregulation of Nck2 in metastatic human melanoma cells would restore E-cadherin expression remains to be determined. The gene discussed is NCK2; the disease is melanoma.